Photo of Nancy L. Shapiro

Nancy L. Shapiro


Clinical Professor, College of Pharmacy - Pharmacy Practice
Clinical Pharmacist in Ambulatory Care, College of Pharmacy
Assistant Head for Education, College of Pharmacy - Department of Pharmacy Practice

Contact

Address:

833 S. Wood St. M/C 886 Room 164, Chicago, IL

Office Phone:

(312) 413-8785 (work)

About

Overview:
Nancy L. Shapiro, Pharm.D., FCCP, BCACP, CACP is Clinical Professor and Assistant Head for Education, Department of Pharmacy Practice, University of Illinois at Chicago (UIC) College of Pharmacy. She serves as Coordinator and Clinical Pharmacist of the pharmacist-managed Antithrombosis Clinic at the University of Illinois Hospital and Health Sciences System. She is also Director of the PGY2 Ambulatory Care Pharmacy Residency. Dr. Shapiro received her BS and PharmD from the University of Iowa. She completed a primary care specialty residency at UIC in 1996, earned her BCPS in 1997, her FCCP in 2010, her BCACP in 2016, and became a Certified Anticoagulation Provider in 2017. She completed her term on the ACCP Board of Regents in 2019.

Dr. Shapiro has been a clinical pharmacist, scholar, and educator in all aspects of anticoagulation pharmacotherapy since 1997. She has trained numerous UIC students and residents and international trainees looking to create anticoagulation services at their own institutions, or gain additional clinical skills in this practice area.

Research Interests:
Her research areas of interest include all aspects of managing anticoagulation, with special attention to venous thromboembolism, stroke prevention for atrial fibrillation, and pregnancy. She is the Clinical Pharmacist Lead for the UIC Research Communication Center to support
ACTIV-4C COVID-19 Post-hospital Thrombosis Prevention Study. A multicenter, adaptive, prospective, randomized platform trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge Clinicaltrial.gov NCT04650087 and ACTIV-4b COVID-19 Outpatient Thrombosis Prevention Trial: A multicenter adaptive randomized placebo-controlled platform trial evaluating the efficacy and safety of antithrombotic strategies in COVID-19 adults not requiring hospitalization at time of diagnosis. Clinicaltrials.gov NCT04498273.

Teaching Statement:
Key Teaching Highlights include the following:
PharmD Courses Coordinated and Instructed:
Spring 2020 to present: Co-coordinator, Clinical Research Design Elective, PMPR 390.
Fall 2019 to present: Co-coordinator, Personal and Professional Development, PHAR 463.

PharmD Lectures/Class Activities:
Fall 2016 –present: Lecturer, BPS 360. “Pharmacology of the Anticoagulants.”
Spring 2018-present: Lecturer and Recitation Leader, PHAR 505. “Treatment and Prophylaxis of Venous Thromboembolism” and “Anticoagulation in Special Populations”.
Spring 2007 –2018: Lecturer and Recitation facilitator, PHAR 408. “Osteoarthritis” and “Systemic Lupus Erythematosus.”

Clinical Teaching:
Fall 1996 – present: Preceptor – Introductory Pharmacy Practice Experiences and Advanced Pharmacy Practice Experiences for Doctor of Pharmacy Students. Current site in the UI-Health Antithrombosis Clinic, while past sites included the Pharmaceutical Care Center and Nutrition and Wellness Center.
Fall 1996 – present: Residency Preceptor – PGY1 Pharmacy, PGY2 Ambulatory Care, PGY2 Cardiology, and PGY1 Community Pharmacy Residents, at the UI-Health Antithrombosis Clinic, with past sites including the Pharmaceutical Care Center and Nutrition and Wellness Center.

Residency Involvement:
July 2009 – present Director, PGY2 Ambulatory Care Pharmacy Residency, ASHP-accredited. University of Illinois at Chicago College of Pharmacy
Sept. 2005- 2012: UIC Coordinator for Supervalu/UIC Community Pharmacy Residency
July 2007- 2009: Director, PGY1 Pharmacy Residency, ASHP-accredited

International Teaching Experience:
July 2013 – July 2019 Coordinator, and instructor, Summer International Pharmacy Student Experience “Contemporary Clinical Pharmacy Practice and Education” for visiting students and pharmacists from 10 different regions around the world.
Sept. 2019: Lecturer and Live, video-linked recitation leader, University of Hong Kong with the delivery of their Master of Science in Advanced Clinical Pharmacy.
June 2015-present: External Examiner for Research Projects: Master of Clinical Pharmacy, Department of Pharmacology and Pharmacy, University of Hong Kong.
2014 to present: Live, video-linked recitation leader, University of Malta Master of Science
in Advanced Clinical Pharmacy and Doctor of Pharmacy Programs.

Teaching and Supervision

Personal&Professional Develop (PHAR 463), 8/23/2021 – 12/3/2021
Personal&Professional Develop (PHAR 463), 8/23/2021 – 12/3/2021
Personal&Professional Develop (PHAR 463), 8/23/2021 – 12/3/2021
Personal&Professional Develop (PHAR 463), 8/23/2021 – 12/3/2021
Spec Project in Pharm Pract (PMPR 390), 1/11/2021 – 4/30/2021
Personal&Professional Develop (PHAR 463), 8/24/2020 – 12/4/2020
Personal&Professional Develop (PHAR 463), 8/24/2020 – 12/4/2020
Personal&Professional Develop (PHAR 463), 8/24/2020 – 12/4/2020
Personal&Professional Develop (PHAR 463), 8/24/2020 – 12/4/2020

Selected Grants

★ CTA COVID19 ACTIV-IV Post Hospital Platform, University of Pittsburgh., 12/1/2020 - 11/30/2021, Obligated Amount: $1924936; Anticipated Amount: $1924936

★ COVID19 ACTIV-4 Research Communications Center, University of Pittsburgh., 7/1/2020 - 5/31/2021, Obligated Amount: $4216708; Anticipated Amount: $4216708

The effectiveness of a technology - based, pharmacist - led, behavioral - education intervention on rivarox aban adherence in an inner - city population., 10/2015 - 2017, No Obligated Amount Set; No Anticipated Amount Set

Patient centered anticoagulation self-monitoring in minority patients, National Institutes of Health., 2/2013 - 2018, Obligated Amount: $526567.00; No Anticipated Amount Set

Impact of Novel Oral Anticoagulants on Quality of Life in an Inner City Underserved Population, American Pharmacists Association Foundation., 7/2012 - 2014, Obligated Amount: $1500; No Anticipated Amount Set

Identifying Trends in Patient Characteristics Associated with Enrollment in a Community Pharmacist-led Diabetes Education Program, American Pharmacists Association Foundation., 7/2011 - 2012, Obligated Amount: $1000; No Anticipated Amount Set

Functional and Clinical Significance of the CYP2C9*8 Allele, Amer Heart Assn., 7/1/2010 - 6/30/2013, Obligated Amount: $143000; Anticipated Amount: $143000

Assessing Patient Knowledge and Satisfaction from a Community Pharmacist-led Hypertension Class in the Grocery Story Pharmacy Setting, American Pharmacists Association Foundation., 7/2010 - 2011, Obligated Amount: $1000; No Anticipated Amount Set

Evaluation of the ProTime® InRhythm™ Microcoagulation System by Inexperienced Patients Self-Testers, International Technidyne Corporation., 4/2010 - 2013, Obligated Amount: $55609.37; No Anticipated Amount Set

Selected Publications

★ Kim, Yoo Jin, DeLisa, Julie A, Chung, Yu-Che, Shapiro, Nancy L, Kolar Rajanna, Subhash K, Barbour, Edward, Loeb, Jeffrey A, Turner, Justin, Daley, Susan, Skowlund, John, Krishnan, Jerry A. (2021). Recruitment in a research study via chatbot versus telephone outreach: a randomized trial at a minority-serving institution.. Journal of the American Medical Informatics Association. doi:10.1093/jamia/ocab240.

★ Connors, JM, Brooks, MM, Sciurba, FC, Krishnan, JA, Bledsoe, JR, Kindzelski, A, Baucom, AL, Kirwan, BA, Eng, H, Martin, D, Zaharris, E, Everett, B, Castro, L, Shapiro, NL, Lin, JY, Hou, PC, Pepine, CJ, Handberg, E, Haight, DO, Wilson, JW, Majercik, S, Fu, Z, Zhong, Y, Venugopal, V, Beach, S, Wisniewski, S, Ridker, PM. (2021). Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients with Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial. JAMA – Journal of the American Medical Association, 326, (17), 1703-1712. doi:10.1001/jama.2021.17272.

★ Sobeski, LM, Schumacher, CA, Alvarez, NA, Anderson, KC, Bradley, B, Crowe, SJ, Merlo, JR, Nyame, A, Rivera, KS, Shapiro, NL, Spencer, DD, Van Dril, E. (2021). Medication access: Policy and practice opportunities for pharmacists. JACCP Journal of the American College of Clinical Pharmacy, 4, (1), 113-125. doi:10.1002/jac5.1373.

★ Uppuluri, EM, Shapiro, NL. (2020). Development of pulmonary embolism in a nonhospitalized patient with COVID-19 who did not receive venous thromboembolism prophylaxis. American Journal of Health-System Pharmacy, 77, (23), 1957-1960. doi:10.1093/ajhp/zxaa286.

★ Shapiro, NL, Lin, HW, Lau, AH. (2020). Creation and delivery of a clinical pharmacy practice and education program for international participants in the United States. JACCP Journal of the American College of Clinical Pharmacy, 3, (5), 913-919. doi:10.1002/jac5.1281.

★ Uppuluri, EM, McComb, MN, Shapiro, NL. (2020). Implementation of a Direct Oral Anticoagulation Screening Service at a Large Academic Medical Center Provided by a Pharmacist-managed Antithrombosis Clinic as a Method to Expand Antithrombotic Stewardship Efforts. Journal of Pharmacy Practice, 33, (3), 271-275. doi:10.1177/0897190018799200.

★ Shapiro, Nancy. (2018). Anticoagulation in Pregnancy. Anticoagulation Therapy: A Point of Care Guide. American Society of Health-System Pharmacists.

★ Shapiro, NL, Hellenbart, Erika. (2018). Thrombosis. Applied Therapeutics: The clinical use of drugs.. (pp. 174-206). Wolters Kluwer Health, Inc..

★ Atanda, A, Shapiro, NL, Stubbings, JA, Groo, V. (2017). Implementation of a new clinic-based, pharmacist-managed PCSK9 inhibitor consultation service. Journal of Managed Care and Specialty Pharmacy, 23, (9), 918-925. doi:10.18553/jmcp.2017.23.9.918.

★ Stone, RH, Bress, AP, Nutescu, EA, Shapiro, NL. (2016). Upper-Extremity Deep-Vein Thrombosis: A Retrospective Cohort Evaluation of Thrombotic Risk Factors at a University Teaching Hospital Antithrombosis Clinic. Annals of Pharmacotherapy, 50, (8), 637-644. doi:10.1177/1060028016649601.

Professional Leadership

ACCP Awards Committee, 9/1/2020 - Present

Taskforce for Medication Access, American College of Clinical Pharmacy, 2019 - 2019

ACCP Board of Regents, American College of Clinical Pharmacy, 5/1/2016 - 10/28/2019

Board of Regents, American College of Clinical Pharmacy, 2016 - 2019

PGY2 Ambulatory Care Residency Goals and Objectives, American Society of Health-System Pharmacists, 2015 - 2015

Oversight Panel for ACCP's new P1/P2 Student Research and Drug Literature Competition, the Clinical Research Challenge, American College of Clinical Pharmacy, 2015 - 2015

Awards Committee, American College of Clinical Pharmacy, 2015 - 2015

Task Force on Residency Administration, American College of Clinical Pharmacy, 2014 - 2014

non-specialitst member, 2013 - 2016

Notable Honors

2011, Education and Training PRN Member Recognition Award, American College of Clinical Pharmacy

★ 2010, Fellow, American College of Clinical Pharmacy

Education

Degrees:
B.S, University of Iowa, United States, 1993
Pharm.D., University of Iowa, United States, 1995

Postgraduate Training:
Primary Care Specialty Residency - ASHP Accredited, University of Illinois at Chicago, United States, 1996

Licensures and Certifications

Certified Anticoagulation Care Provider, National Certification Board for Anticoagulation Providers, 1/1/2017 - Present
Board Certified Ambulatory Care Pharmacist, Board of Pharmacy Specialties, 2016 - 2023
Board Certified Pharmacotherapy Specialist, Board of Pharmacy Specialties, 1997 - 2017
Illinois Pharmacist License, Illinois Dept of Professional Regulation, 1995 - Present
Iowa Pharmacist License, Iowa Board of Pharmacy, 1993 - Present
Graduate, ACCP Leadership and Management Academy, American College of Clinical Pharmacy, 2012 - Present
Participant in Pharmacy-Based Immunization Delivery, A Certificate Training Program for Pharmacists, American Pharmacist Association, 2000 - Present
Selected participant for Lipid Service Traineeship Program in Richmond, Virginia, National Pharmacy Cholesterol Council, 1998 - 1998